Fibroblast growth factor-2

被引:294
作者
Okada-Ban, M [1 ]
Thiery, JP [1 ]
Jouanneau, J [1 ]
机构
[1] Inst Curie, CNRS, UMR 144, Lab Morphogenesis & Tumor Progress, F-75248 Paris 05, France
基金
澳大利亚研究理事会;
关键词
high affinity receptor; nucleus; differentiation; angiogenesis;
D O I
10.1016/S1357-2725(99)00133-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Fibroblast growth factor-2 (FGF-2) is a heparin-binding growth factor which occurs in several isoforms resulting from alternative initiations of translation: an 18 kD cytoplasmic isoform and four larger molecular weight nuclear isoforms (22, 22.5, 24 and 34 kD). FGF-2 has pleiotropic roles in many cell types and tissues. it is a motogenic, angiogenic and survival factor which is involved in cell migration, cell differentiation and in a variety of developmental processes. Although devoid of signal peptide, it could be secreted. It acts mainly through a paracrine/autocrine mechanism involving high affinity transmembrane receptors and heparan sulfate proteoglycan low affinity receptors, but also through still unknown intracrine process(es) on intracellular targets. FGF-2 has many biological functions which are probably isoform-specific. Nevertheless, FGF-2 is not essential for embryonic development as knock-out mice for the growth factor are viable and fertile although they exhibit abnormalities in neuronal differentiation. Use of FGF-2 as therapeutic agent for the treatment of ischemic cardiovascular disease is promising and clinical trials are in progress. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:263 / 267
页数:5
相关论文
共 19 条
[1]
Nuclear activities of basic fibroblast growth factor: Potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals [J].
Arese, M ;
Chen, Y ;
Florkiewicz, RZ ;
Gualandris, A ;
Shen, B ;
Rifkin, DB .
MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (05) :1429-1444
[2]
Arnaud E, 1999, MOL CELL BIOL, V19, P505
[3]
THE FGF FAMILY OF GROWTH-FACTORS AND ONCOGENES [J].
BASILICO, C ;
MOSCATELLI, D .
ADVANCES IN CANCER RESEARCH, 1992, 59 :115-165
[4]
A secreted FGF-binding protein can serve as the angiogenic switch in human cancer [J].
Czubayko, F ;
LiaudetCoopman, EDE ;
Aigner, A ;
Tuveson, AT ;
Berchem, GJ ;
Wellstein, A .
NATURE MEDICINE, 1997, 3 (10) :1137-1140
[5]
Dinney CPN, 1998, CANCER RES, V58, P808
[6]
Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice [J].
Dono, R ;
Texido, G ;
Dussel, R ;
Ehmke, H ;
Zeller, R .
EMBO JOURNAL, 1998, 17 (15) :4213-4225
[7]
GOSPODAROWICZ D, 1975, J BIOL CHEM, V250, P2515
[8]
FGF-2 and FGF-1 expressed in rat bladder carcinoma cells have similar angiogenic potential but different tumorigenic properties in vivo [J].
Jouanneau, J ;
Plouet, J ;
Moens, G ;
Thiery, JP .
ONCOGENE, 1997, 14 (06) :671-676
[9]
Leconte I, 1998, DEV DYNAM, V213, P421, DOI 10.1002/(SICI)1097-0177(199812)213:4<421::AID-AJA7>3.0.CO
[10]
2-B